IP Library Granted Patent US 9,675,759
Granted Patent B2
US 9,675,759 · App. 15/180,495 · Granted Jun 13, 2017

Devices, systems, and methods for delivering fluid to tissue

Inventors: Justin M. Crank (Maple Grove, MN); Suranjan Roychowdhury (Plymouth, MN); Carey J. Becker (Savage, MN)
Assignee: Astora Women's Health Holdings, LLC
A61M5/3007A61B1/018A61B90/39A61M5/30A61M5/315A61M25/005A61M25/007A61M25/0054A61M25/04A61M31/00A61B2090/3925A61B2090/3966A61M2205/502A61M2210/1078
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,675,759
App. No.
15/180,495
Granted
Jun 13, 2017
Kind
B2
Abstract

A needleless fluid injection device including a flexible shaft with a proximal end, a distal end, an injection lumen extending from the proximal end to the distal end of the shaft, and at least one injection orifice extending through a wall of the injection lumen at the distal end of the shaft. The injection lumen can include a depth-limiting system ( 462 ) at its distal end for controlling the depth of insertion of the injection lumen relative to a target tissue of a patient. The injection lumen can alternatively or additionally include at least one guidance feature. The injection lumen can alternatively or additionally include at least one flow-modifying protrusion extending from the inner tubular wall of the injection lumen and toward a longitudinal axis of the injection lumen.

Claims (25)

1. A needleless fluid injection device comprising a shaft, the shaft comprising:

a proximal end;

a distal end;

a wall extending from the proximal end to the distal end, the wall comprising a first side and an opposite second side that is unbroken from the proximal end to the distal end of the shaft; and

an injection lumen defined by the wall, the injection lumen extending from the proximal end to the distal end of the shaft and comprising a central longitudinal axis,

wherein the second side of the wall comprises at least one interior flow feature extending inwardly towards the central longitudinal axis of the injection lumen adjacent to the distal end of the shaft, and wherein the first side of the wall comprises at least one injection orifice adjacent to the distal end of the shaft.

2. The injection device of claim 1 , wherein the at least one interior flow feature of the unbroken second side of the wall is located adjacent to the at least one injection orifice.

3. The injection device of claim 1 , wherein the at least one interior flow feature of the unbroken second side of the wall is located generally opposite a location at which the at least one injection orifice is located.

4. The injection device of claim 1 , wherein a first interior flow feature of the at least one interior flow feature is located at a location generally opposite a second interior flow feature of the at least one interior flow feature, and wherein the first interior flow feature is located adjacent to at least one injection orifice on the first side of the wall.

5. The injection device of claim 1 , wherein the at least one interior flow feature of the unbroken second side of the wall comprises a convex surface extending in a longitudinal direction of the second wall and extending into the injection lumen.

6. The injection device of claim 1 , wherein the at least one interior flow feature of the unbroken second side of the wall comprises a first surface extending generally perpendicular to the second side of the wall and an angled surface extending from the first surface of the at least one interior flow feature.

7. The injection device of claim 1 , wherein a first interior flow feature of the at least one interior flow feature comprises a convex surface extending in a longitudinal direction of the second wall and extending into the injection lumen, and a second interior flow feature of the at least one interior flow feature comprises a first surface extending generally perpendicular to the second side of the wall and an angled surface extending from the first surface of the at least one interior flow feature.

8. The injection device of claim 1 , wherein multiple interior flow features of the at least one flow feature are spaced at equal distances from each other along a length of the second side of the wall.

9. The injection device of claim 1 , wherein multiple interior flow features of the at least one flow feature are spaced at non-equal distances from each other along a length of the second side of the wall.

10. The injection device of claim 1 , wherein the at least one interior flow feature provides for obstruction or modification of a flow of fluid through the injection lumen.

11. The injection device of claim 1 , wherein a length of a first interior flow feature of the at least one flow feature is the same as a length of a second interior flow feature of the at least one flow feature.

12. The injection device of claim 1 , wherein a length of a first interior flow feature of the at least one flow feature is different than a length of a second interior flow feature of the at least one flow feature.

13. A needleless fluid injection device comprising a shaft, the shaft comprising:

a proximal end;

a distal end;

a wall extending from the proximal end to the distal end, the wall comprising a first side and an opposite second side that is unbroken from the proximal end to the distal end of the shaft; and

an injection lumen defined by the wall and extending from the proximal end to the distal end of the shaft and comprising a central longitudinal axis;

wherein the first side of the wall comprises multiple injection orifices and at least one interior flow feature extending inwardly towards the central longitudinal axis adjacent to the distal end of the shaft.

14. The injection device of claim 13 , wherein the multiple injection orifices are spaced at equal distances from each other along a length of the first side of the wall.

15. The injection device of claim 13 , wherein the multiple injection orifices are spaced at non-equal distances from each other along a length of the first side of the wall.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0542 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2017
From: AMS RESEARCH, LLC
To: AMERICAN MEDICAL SYSTEMS, LLC
Reel/Frame 042092/0417 →
CHANGE OF NAME Recorded Apr 21, 2017
From: ASTORA WOMEN'S HEALTH, INC.
To: ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042310/0682 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2017
From: AMERICAN MEDICAL SYSTEMS, LLC
To: AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
Reel/Frame 042092/0559 →
CHANGE OF NAME Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042310/0335 →
CHANGE OF NAME Recorded Apr 21, 2017
From: AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
To: ASTORA WOMEN'S HEALTH, INC.
Reel/Frame 042310/0640 →
Continuity (8)
Continuation 14153709 · Jan 13, 2014
Division 13260869
Provisional Application 61226855 · Jul 20, 2009
Provisional Application 61226849 · Jul 20, 2009
Provisional Application 61226832 · Jul 20, 2009
Provisional Application 61226805 · Jul 20, 2009
Provisional Application 61226796 · Jul 20, 2009
Related Publication 20160296705A1 · Oct 13, 2016